← 返回

靶向间皮素膜近端结构域的 CAR 记忆样 NK 细胞在卵巢癌中展现出有前景的活性

英文原题:CAR memory-like NK cells targeting the membrane proximal domain of mesothelin demonstrate promising activity in ovarian cancer.

查看英文原题

CAR memory-like NK cells targeting the membrane proximal domain of mesothelin demonstrate promising activity in ovarian cancer.

PubMed 2024/07/12(内容时间) Sci Adv Q1 · IF 13.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

上皮性卵巢癌(EOC)仍然是最致命的妇科癌症之一。细胞因子诱导的记忆样(CIML)自然杀伤(NK)细胞在临床前和早期临床试验中显示出有希望的结果。在本研究中,CIML NK细胞对一组EOC细胞系表现出优越的抗肿瘤反应,活化受体表达增加,参与细胞周期/增殖的基因上调,抑制性/抑制性基因下调。转导了靶向间皮素(MSLN)膜近端结构域的嵌合抗原受体(CAR)的CIML NK细胞进一步改善了对表达MSLN的EOC细胞和患者来源的异种移植肿瘤细胞的抗肿瘤反应。CAR武装的CIML NK细胞在患者来源的腹水中显著降低了其功能障碍,转录组学变化与代谢改变和强直信号传导相关,作为潜在机制。最后,MSLN-CAR CIML NK细胞的过继转移在异种移植小鼠中显示出显著的肿瘤生长抑制并阻止了转移扩散,支持其作为EOC有效治疗策略的潜力。

展开英文摘要原文

Epithelial ovarian cancer (EOC) remains one of the most lethal gynecological cancers. Cytokine-induced memory-like (CIML) natural killer (NK) cells have shown promising results in preclinical and early-phase clinical trials. In the current study, CIML NK cells demonstrated superior antitumor responses against a panel of EOC cell lines, increased expression of activation receptors, and up-regulation of genes involved in cell cycle/proliferation and down-regulation of inhibitory/suppressive genes.

CIML NK cells transduced with a chimeric antigen receptor (CAR) targeting the membrane-proximal domain of mesothelin (MSLN) further improved the antitumor responses against MSLN-expressing EOC cells and patient-derived xenograft tumor cells.

CAR arming of the CIML NK cells subtanstially reduced their dysfunction in patient-derived ascites fluid with transcriptomic changes related to altered metabolism and tonic signaling as potential mechanisms. Lastly, the adoptive transfer of MSLN-CAR CIML NK cells demonstrated remarkable inhibition of tumor growth and prevented metastatic spread in xenograft mice, supporting their potential as an effective therapeutic strategy in EOC.

论文信息

作者
Tarannum M、Dinh K、Vergara J、Birch G、Abdulhamid YZ、Kaplan IE、Ay O、Maia A
单位
Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.United States
文献类型
非美国政府资助研究
期刊
Science advances2024 Jul 12
原文标识
PubMed 38996027 · DOI 10.1126/sciadv.adn0881